Celldex Therapeutics reported $400K in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
AbbVie USD 17.4B 410M Sep/2026
Agenus USD 33.7M 500K Mar/2026
Amgen USD 10.4B 300M Sep/2026
Bristol-Myers Squibb USD 13.07B 100M Sep/2026
Celldex Therapeutics USD 400K 378K Sep/2026
Glaxosmithkline GBP 8.89B 1.2B Sep/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Northwest Biotherapeutics USD 494K 294K Mar/2026
Pfizer USD 16.6B 1.57B Sep/2026
Rigel Pharmaceuticals USD 55.31M 18.47M Sep/2024
Roche Holding CHF 30.36B 14.71B Jun/2026